Judicialization of medicines: a systematic review of the literature in Brazil between the years 2015 and 2019
DOI:
https://doi.org/10.47456/rbps.v22i3.32533Keywords:
Judicialization of health, Judicialization of access to medicines, RighttohealthAbstract
Introduction: The judicialization of health, especially regarding the requisition of medicines, has become popular throughout the country, in which those who feel denied the right to access health, seek justice through the guarantee of access. However, sometimes judicialization for individual purposes starts to reverse the logic of the principles of the Unified Health System when it privileges only one individual and not the need for the collective. This context reflects weak points in public policies, which call for solutions that facilitate access to pharmaceutical assistance and minimize costs arising from judicialization. Objective: To identify studies about the judicialization of health, with a focus on medicines supply. Methods: This is a systematic review study based on Methodi Ordinatio, carried out in Scopus, Scielo and Science Direct databases, considering the years 2015 to 2019. Results: Of the total of 706 articles 16 were selected originating four categories: authors profile, characteristics of the causes, cost of medication judicialization and issues that permeate medication judicialization. Mostly Brazilian studies, with lawsuits filed by different age groups requesting low and high-cost drugs, predominantly for chronic diseases. Conclusion: The interference of the judiciary in the access to medicines aims to guarantee the right to health, but it interferes principles of the health system. The judicialization of medicines has been growing in the country, establishing the conflict between right to health guaranteed by the Federal Constitution and structuring of services for its effectiveness.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors and reviewers must disclose any financial, professional, or personal conflicts of interest that could influence the results or interpretations of the work. This information will be treated confidentially and disclosed only as necessary to ensure transparency and impartiality in the publication process.
Copyright
RBPS adheres to the CC-BY-NC 4.0 license, meaning authors retain copyright of their work submitted to the journal.
- Originality Declaration: Authors must declare that their submission is original, has not been previously published, and is not under review elsewhere.
- Publication Rights: Upon submission, authors grant RBPS the exclusive right of first publication, subject to peer review.
- Additional Agreements: Authors may enter into non-exclusive agreements for the distribution of the RBPS-published version (e.g., in institutional repositories or as book chapters), provided the original authorship and publication by RBPS are acknowledged.
Authors are encouraged to share their work online (e.g., institutional repositories or personal websites) after initial publication in RBPS, with appropriate citation of authorship and original publication.
Under the CC-BY-NC 4.0 license, readers have the rights to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material.
These rights cannot be revoked, provided the following terms are met:
- Attribution: Proper credit must be given, a link to the license provided, and any changes clearly indicated.
- Non-Commercial: The material cannot be used for commercial purposes.
- No Additional Restrictions: No legal or technological measures may be applied to restrict others from doing anything the license permits.
